The renewable chemicals market seems to be quiet in general but I am hoping to get fresh updates next month especially in the bioplastics sector when I attend the NPE International Plastics trade show next month. And yes, I am also looking forward to getting out of New York City and into the warmer weather of Orlando.
In the meantime, as I work on my Bio-Materials newsletter, here is a recent bio-succinic acid news from Reverdia. The company announced that it has been granted exclusive rights to newly approved patents from its parent company, DSM, covering innovative yeast-based succinic acid production technology. These patents have been approved in Europe, Japan and Canada covering key technology to make economically-viable and sustainable bio-based succinic acid.
Reverdia is currently producing bio-succinic acid at Roquette’s biorefinery site in Cassano, Italy, with 10 ktpa capacity. Reverdia is a joint venture between DSM and Roquette.
Reverdia plans to offer its bio-based succinic acid production technology under license.
- CA 2730595 entitled LOW PH DICARBOXYLIC ACID PRODUCTION was granted in Canada on 16 December 2014.
- EP2220232 entitled SUCCINIC ACID PRODUCTION IN A EUKARYOTIC CELL was granted in Europe on 3 September 2014.
- JP5641938 entitled SUCCINIC ACID PRODUCTION IN A EUKARYOTIC CELL was granted in Japan on 7 November 2014.
- CA 2704654 entitled SUCCINIC ACID PRODUCTION IN A EUKARYOTIC CELL was granted in Canada on 10 February 2015.
As for news from other bio-succinic acid producers, the blog has not heard anything coming from Myriant, Succinity and BioAmber, although the latter recently announced a new chief financial officer, and it should soon release its earnings results for Q4.